(Q43839533)
Statements
1 reference
Medical costs in the US of clinical events associated with oral anticoagulant (OAC) use compared to warfarin among non-valvular atrial fibrillation patients ≥75 and <75 years of age, based on the ARISTOTLE, RE-LY, and ROCKET-AF trials (English)
1 reference
Steve Deitelzweig
1 reference
Alpesh Amin
1 reference
Yonghua Jing
1 reference
Dinara Makenbaeva
1 reference
Daniel Wiederkehr
1 reference
Jay Lin
1 reference
John Graham
1 reference
8 August 2013
1 reference
1 reference
Identifiers
1 reference